Veterans Special Report

News & Research

Hyperbaric Oxygen Therapy has been used for the better part of two centuries. Search our  arhives below for past HBOT news and research or scroll down for the latest.

The Latest HBOT News & Research

Therapeutic use of hyperbaric oxygen therapy for children with autism spectrum disorder

Jul 14, 2017 | ,

Autism spectrum disorder (ASD) is neurodevelopment disorder, characterized by impairment in social interaction, verbal and non-verbal communication and the presence of restricted and repetitive stereotyped behaviors. The condition manifests within the first 3 years of life and persists till adulthood. At present, the etiology of ASD is largely unknown, but genetic, environmental, immunological, and neurological factors are thought to play a role in the development of ASD. The prevalence of ASD has increased dramatically in the past few decades. According to current estimates from the United States Centers for Disease Control and Prevention (CDC) as many as 1 in 91 children have ASD in USA.

Clinical Trial – Spinal Prilocaine for Caesarian Sections

Jul 13, 2017 | , ,

Prilocaine theoretically could provide faster onset because of its lower pKa (7,7) compared
to bupivacaine (8,1). The primary objective of this prospective double blind randomized trial
is to determine block onset of spinal hyperbaric prilocaine compared to bupivacaine, both
with a small dose of sufentanyl as an additive.The primary hypothesis is that a significant
larger amount of patients will gain surgical readiness within 8 minutes after spinal
injection of prilocaine with sufentanyl compared to bupivacaine with sufentanyl. Surgical
readiness is defined as a sensory block level of T5 tested by loss of cold sensation.